Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study

Trial Profile

Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Mar 2017

At a glance

  • Drugs Adalimumab (Primary) ; Methotrexate
  • Indications Psoriasis
  • Focus Therapeutic Use
  • Acronyms CLEAR
  • Sponsors AbbVie
  • Most Recent Events

    • 20 Mar 2017 Status changed from active, no longer recruiting to completed.
    • 16 Jan 2017 Status changed from recruiting to active, no longer recruiting.
    • 14 Apr 2016 Planned number of patients changed from 200 to 50.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top